XML 20 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2012
Quarterly Financial Data (Unaudited)  
Quarterly financial data

 

 

 
  2012 Quarter Ended  
 
  December 31   September 30   June 30   March 31  
 
  (In thousands, except per share data)
 

Revenue:

                         

Revenue from collaboration agreement

  $ 72,936   $ 70,744   $ 72,704   $ 72,031  

Product revenue

    45,319     18,636     -     -  

Royalty revenue

    8,163     131     -     -  

Contract revenue from collaborations

    1,500     -     -     -  
                   

Total revenue

    127,918     89,511     72,704     72,031  
                   

Operating expenses:

                         

Cost of goods sold (excludes amortization of certain intangible assets)

    832     496     -     -  

Research and development

    82,572     85,667     76,356     80,660  

Selling, general and administrative

    74,566     61,747     48,907     38,944  

Contingent consideration expense (benefit)

    2,937     9,843     53,214     3,178  

Intangible asset amortization

    5,221     4,110     -     -  
                   

Total operating expenses

    166,128     161,863     178,477     122,782  
                   

Income (loss) from operations

    (38,210 )   (72,352 )   (105,773 )   (50,751 )

Investment income, net

    675     625     619     758  

Interest expense

    (5,659 )   (5,456 )   (5,374 )   (5,296 )

Other income (expense)

    (728 )   (1,194 )   4,464     (905 )

Provision (benefit) for income taxes

    (1,000 )   (95,773 )   (15 )   18  
                   

Net income (loss)

    (42,922 )   17,396     (106,049 )   (56,212 )
                   

Basic net income (loss) per share

  $ (0.64 ) $ 0.26   $ (1.65 ) $ (0.88 )
                   

Diluted net income (loss) per share

  $ (0.64 ) $ 0.25   $ (1.65 ) $ (0.88 )
                   

 

 
  2011 Quarter Ended  
 
  December 31   September 30   June 30   March 31  
 
  (In thousands, except per share data)
 

Revenue:

                         

Revenue from collaboration agreement

  $ 76,821   $ 75,041   $ 67,956   $ 67,145  

Contract revenue from collaborations

    160,211     -     -     -  
                   

Total revenue

    237,032     75,041     67,956     67,145  
                   

Operating expenses:

                         

Research and development

    83,990     58,532     63,045     62,494  

Selling, general and administrative

    52,611     42,642     38,236     34,471  

Contingent consideration expense (benefit)

    (116,663 )   5,945     5,755     11,495  

Lease termination exit costs

    (4,540 )   130     10,727     -  
                   

Total operating expenses

    15,398     107,249     117,763     108,460  
                   

Income (loss) from operations

    221,634     (32,208 )   (49,807 )   (41,315 )

Investment income, net

    678     435     645     649  

Interest expense

    (5,069 )   (5,112 )   (5,041 )   (5,002 )

Other income (expense)

    (326 )   25     (340 )   (3,462 )

Provision (benefit) for income taxes

    242     -     -     32  
                   

Net income (loss)

  $ 216,675   $ (36,860 ) $ (54,543 ) $ (49,162 )
                   

Basic net income (loss) per share

  $ 3.40   $ (0.58 ) $ (0.86 ) $ (0.78 )
                   

Diluted net income (loss) per share

  $ 3.16   $ (0.58 ) $ (0.86 ) $ (0.78 )